SungjuneKimMD PhD
Radiation Oncology • Jacksonville, FLHematologic Malignancies, Melanoma, Skin Cancer
Vice Chair of Research at Mayo Clinic Florida
Overview of Dr. Kim
Dr. Sungjune Kim is a radiation oncologist in Jacksonville, FL. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 7 years. He has more than 60 publications and over 500 citings.
Office
4500 San Pablo Rd
Jacksonville, FL 32224- Is this information wrong?
Education & Training
University of South Florida MorsaniResidency, Radiation Oncology, 2011 - 2015
Vanderbilt University School of MedicineClass of 2010
Certifications & Licensure
FL State Medical License 2015 - 2025
VA State Medical License 2010 - 2011- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 1 citationsFeasibility and Toxicity of Full-Body Volumetric Modulated Arc Therapy Technique for High-Dose Total Body Irradiation.Emily Keit, Casey Liveringhouse, Nicholas Figura, Joseph Weygand, Maria L Sandoval, Genevieve Garcia, Julia Peters, Michael Nieder, Rawan Faramand, Farhad Khimani, Sun...> ;Technology in Cancer Research & Treatment. 2023 Jun 8
- 11 citationsEpigenetic state determines the in vivo efficacy of STING agonist therapy.Rana Falahat, Anders Berglund, Patricio Perez-Villarroel, Ryan M Putney, Imene Hamaidi, Sungjune Kim, Shari Pilon-Thomas, Glen N Barber, James J Mulé> ;Nature Communications. 2023 Mar 22
- 2 citationsDose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Sm...Casey L Liveringhouse, Kujtim Latifi, Amalin G Asous, Nghi B Lam, Stephen A Rosenberg, Thomas J Dilling, Gretchen V MacMillan, Alberto A Chiappori, Eric B Haura, Ben C...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Jul 15
- Join now to see all
Journal Articles
- Immune Interconnectivity of Anatomically Distant Tumors as a Potential Mediator of Systemic Responses to Local TherapySungjune Kim, Eduardo G. Moros, Brian J. Czerniecki, Nature
Press Mentions
SBRT Does Not Improve Efficacy of Nivo-Ipi in Advanced Merkel Cell CarcinomaSeptember 27th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
